Hôpital Beaujon
About Hôpital Beaujon
The Beaujon Hospital is located in Clichy, Paris, France and is operated by APHDP. It was named after Nicolas Beaujon, an eighteenth-century French banker. It opened in 1935 and was designed by Jean Walter.
There are 464 beds in Hôpital Beaujon.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Assistance Publique - Hôpitaux de Paris
40
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
22
GERCOR - Multidisciplinary Oncology Cooperative Group
18
Gilead Sciences
15
Janssen Research & Development, LLC
9
Nantes University Hospital
9
Celgene
6
Hoffmann-La Roche
6
Pfizer
6
Centre Hospitalier Universitaire de Besancon
5
Federation Francophone de Cancerologie Digestive
5
Clinical Trials at Hôpital Beaujon
During the past decade, Hôpital Beaujon conducted 160 clinical trials. In the 10-year time frame, 160 clinical trials started and 43 clinical trials were completed, i.e. on
average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 23 clinical trials were completed. i.e. 44.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649
Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
1999-09-01
Unknown status
Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
2000-10-01
Unknown status
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
1999-01-01
Unknown status
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
2003-05-01
Completed
97
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
2003-11-01
2007-07-01
Completed
358
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôpital Beaujon" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 40 trials, followed by "Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives" with 22 trials
sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 18 trials sponsored, "Gilead Sciences" with 15 trials sponsored and "Janssen Research & Development, LLC"
with 15 trials sponsored. Other sponsors include 206 different institutions and
companies that sponsored additional 121 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Beaujon"
#1 collaborator was "Ministry of Health, France" with 8 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "National Cancer Institute, France" with 5 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 4 trials as a collaborator and "AbbVie" with 3 trials as a collaborator. Other collaborators include 110 different institutions and companies that were
collaborators in the rest 104 trials.
Clinical Trials Conditions at Hôpital Beaujon
According to Clinical.Site data, the most researched conditions in "Hôpital Beaujon" are
"Ulcerative Colitis" (25 trials), "Crohn's Disease" (22 trials), "Crohn Disease" (12 trials), "Hepatocellular Carcinoma" (12 trials) and "Pancreatic Cancer" (10 trials). Many other conditions were trialed in "Hôpital Beaujon" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Beaujon
Most popular intervention types in "Hôpital Beaujon" are "Drug" (193 trials), "Other" (46 trials), "Procedure" (36 trials), "Device" (31 trials) and "Biological" (17 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (46 trials), "Gemcitabine" (8 trials), "JNJ-73763989" (7 trials), "gemcitabine hydrochloride" (7 trials) and "radiation therapy" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Beaujon
The vast majority of trials in "Hôpital Beaujon" are
312 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Hôpital Beaujon
Currently, there are 86 active trials in "Hôpital Beaujon".
3 are not yet recruiting,
46 are recruiting,
34 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 174 completed trials in Hôpital Beaujon,
2 suspended trials,
and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Beaujon, 9 "Phase 1"
clinical trials were conducted, 78 "Phase 2" clinical
trials and 106 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 19 trials, and there were
also 54 trials that are defined as “Not Applicable".